Filing Details

Accession Number:
0001225208-10-023523
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-28 16:07:51
Reporting Period:
2010-10-26
Filing Date:
2010-10-28
Accepted Time:
2010-10-28 16:07:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901458 M Peter Nicholas One Boston Scientific Place
Natick MA 01760-1537
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-10-26 50,000 $0.00 9,112,125 No 4 J Direct
Common Stock Disposition 2010-10-26 25,000 $6.29 3,681,021 No 4 S Indirect By Ltd. Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 S Indirect By Ltd. Partnership
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Forward Sale Contract (obligation to sell) Disposition 2010-10-26 50,000 $0.00 50,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-10-26 2010-10-26 No 4 J Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,413,088 Indirect By Trust 2
Footnotes
  1. On October 26, 2010, the reporting person settled a prepaid variable contract originally entered into on October 26, 2009. At the initiation of the contract, the bank paid $363,428.84 to the reporting person.
  2. The forward sale contract obligated the reporting person to deliver to the bank at maturity up to 50,000 shares of the Issuer's common stock depending on market prices at maturity. If the market price per share at maturity was equal to or less than the floor price of $8.5162 per share, the reporting person would deliver 50,000 shares to the bank. If the market price per share at maturity was greater than the floor price, the reporting person would deliver a fewer number of shares. The closing market price per share on October 26, 2010 was $6.29. Accordingly, the reporting person transferred to the bank 50,000 shares of the Issuer's common stock.
  3. Sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
  4. The weighted average sales price reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $6.305 to $6.2806. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
  5. Shares held by a trust of which the reporting persons spouse and brother are trustees and the reporting person's spouse and children are beneficiaries.